OOIR: Observatory of International Research

Papers

(The H4-Index of Harm Reduction Journal is 25. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-02-01 to 2025-02-01.)

Article	Citations
The underbelly of E-cigarette advertising: regulating online markets on social media platforms	90
Social and environmental determinants influencing injection drug use and HIV risk among two sister cities on the US–Mexico border: a comparative cross-sectional study, 2016–2018	83
Community-based respondent-driven sampling as a strategy for drug use surveillance in a large French urban area	59
Municipal police support for harm reduction services in officer-led referrals of people who inject drugs in Tijuana, Mexico	47
Accessing needle exchange services in disasters for remote areas of Aotearoa New Zealand	47
How a sample of English stop smoking services and vape shops adapted during the early COVID-19 pandemic: a mixed-methods cross-sectional survey	46
How post overdose response efforts can address social determinants of health among people who use drugs: perspectives from the New York State Department of Health (NYSDOH) Post Overdose Response Team	45
The acceptability of overdose alert and response technologies: introducing the TPOM-ODART framework	41
Nasal administration of diacetylmorphine improved the adherence in a patient receiving heroin-assisted treatment	41
Assessing experts’ perspectives on challenges in substance misuse prevention, harm reduction, and treatment to shape funding priorities in New York State	40
Interim opioid agonist treatment for opioid addiction: a systematic review	40
The hazardous (mis)perception of Self-estimated Alcohol intoxication and Fitness to drivE—an avoidable health risk: the SAFE randomised trial	38
High prevalence of hepatitis B virus susceptibility among persons undergoing community-based hepatitis C virus treatment	37
Acceptability of a pilot motivational interviewing intervention at public health facilities to improve the HIV treatment cascade among people who inject drugs in Indonesia	35
Reported adverse events related to use of hepatitis C virus direct-acting antivirals with opioids: 2017–2021	34
The generative potential of mess in community-based participatory research with young people who use(d) drugs in Vancouver	33
Remote harm reduction services are key solutions to reduce the impact of COVID-19-like crises on people who use drugs: evidence from two independent structures in France and in the USA	33
Acceptability of supervised injection facilities among persons who inject drugs in upstate New York	33
The impact of the COVID-19 pandemic on people who inject drugs accessing harm reduction services in a rural American state	32
Association between heaviness of cigarette smoking and serious psychological distress is stronger in women than in men: a nationally representative cross-sectional survey in Japan	32
Subspecialty physicians’ perspectives on barriers and facilitators of hepatitis C treatment: a qualitative study	29
Does sexuality matter? A cross-sectional study of drug use, social injecting, and access to injection-specific care among men who inject drugs in Melbourne, Australia	29
“I don’t want to die”: a qualitative study of coping strategies to prevent fentanyl-related overdose deaths among people who inject drugs and its implications for harm reduction policies	28
Egocentric network characteristics of people who inject drugs in the Chicago metro area and associations with hepatitis C virus and injection risk behavior	26
Contamination of a drug consumption room with drugs and potential risks for social health care workers	26

Patterns of cannabis use, perception of harm, and perceived impact of legislative change in an online sample of young adults from Lebanon: insight on recreational users versus dual motive users